Alharbi Abdullah R, Alali Amer S, Samman Yahya, Alghamdi Nouf A, Albaradie Omar, Almaghrabi Maan, Makkawi Seraj, Alghamdi Saeed, Alzahrani Mohammad S, Alsalmi Mohammed, Karamyan Vardan T, Al Sulaiman Khalid, Aljuhani Ohoud, Alamri Faisal F
King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Front Neurosci. 2022 Jul 27;16:951283. doi: 10.3389/fnins.2022.951283. eCollection 2022.
Stroke is a leading cause of mortality and disability and one of the most common neurological conditions globally. Many studies focused on vitamin D as a stroke risk factor, but only a few focused on its serum level as a predictor of stroke initial clinical severity and recovery with inconsistent results. The purpose of this study was to assess the relationship between serum vitamin D levels and stroke clinical severity at admission and functional independence and disability at discharge in Saudi Arabia.
A retrospective cohort study of adult ischemic stroke patients who had their vitamin D tested and admitted within 7 days of exhibiting stroke symptoms at King Abdulaziz Medical City (KAMC) Jeddah, Saudi Arabia. Based on vitamin D level, the patients were categorized into normal [25(OH)D serum level ≥ 75 nmol/L], insufficient [25(OH)D serum level is 50-75 nmol/L], and deficient [25(OH)D serum level ≤ 50 nmol/L]. The primary outcome was to assess the vitamin D serum level of ischemic stroke patients' clinical severity at admission and functional independence at discharge. The National Institute of Health Stroke Scale (NIHSS) was used to assess the clinical severity, whereas the modified Rankin scale (mRS) was used to assess functional independence and disability.
The study included 294 stroke patients, out of 774, who were selected based on the inclusion and exclusion criteria. The mean age of the participants was 68.2 ± 13.4 years, and 49.3% were male. The patients' distribution among the three groups based on their vitamin D levels is: normal ( = 35, 11.9%), insufficient ( = 66, 22.5%), and deficient ( = 196, 65.6%). After adjusting for potential covariates, regression analysis found a significant inverse relationship of NIHSS based on 25(OH)D serum level (beta coefficient: -0.04, SE: 0.01, = 0.003). Patients with deficient serum vitamin D level also had significantly higher odds of worse functional independence in mRS score [OR: 2.41, 95%CI: (1.13-5.16), = 0.023] when compared to participants with normal vitamin D level.
Low vitamin D levels were associated with higher severity of stroke at admission and poor functional independence and disability at discharge in patients with acute ischemic stroke. Further randomized clinical and interventional studies are required to confirm our findings.
中风是全球死亡率和致残率的主要原因之一,也是最常见的神经系统疾病之一。许多研究聚焦于维生素D作为中风的危险因素,但只有少数研究关注其血清水平作为中风初始临床严重程度和恢复情况的预测指标,且结果并不一致。本研究的目的是评估沙特阿拉伯血清维生素D水平与中风入院时临床严重程度以及出院时功能独立性和残疾情况之间的关系。
对在沙特阿拉伯吉达阿卜杜勒阿齐兹国王医疗城(KAMC)出现中风症状7天内入院并检测了维生素D的成年缺血性中风患者进行回顾性队列研究。根据维生素D水平,将患者分为正常组[25(OH)D血清水平≥75 nmol/L]、不足组[25(OH)D血清水平为50 - 75 nmol/L]和缺乏组[25(OH)D血清水平≤50 nmol/L]。主要结局是评估缺血性中风患者入院时的临床严重程度和出院时的功能独立性的维生素D血清水平。采用美国国立卫生研究院卒中量表(NIHSS)评估临床严重程度,而改良Rankin量表(mRS)用于评估功能独立性和残疾情况。
在774名患者中,根据纳入和排除标准选择了294名中风患者进行研究。参与者的平均年龄为68.2±13.4岁,49.3%为男性。根据维生素D水平,患者在三组中的分布情况为:正常组(n = 35,11.9%)、不足组(n = 66,22.5%)和缺乏组(n = 196,65.6%)。在对潜在协变量进行调整后,回归分析发现基于25(OH)D血清水平的NIHSS存在显著的负相关关系(β系数:-0.04,标准误:0.01,P = 0.003)。与维生素D水平正常的参与者相比,血清维生素D水平缺乏的患者在mRS评分中功能独立性较差的几率也显著更高[比值比:2.41,95%置信区间:(1.13 - 5.16),P = 0.023]。
急性缺血性中风患者中,低维生素D水平与入院时中风严重程度较高以及出院时功能独立性差和残疾情况相关。需要进一步的随机临床和干预研究来证实我们的发现。